SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 325 filers reported holding SEATTLE GENETICS INC in Q2 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,228,000 | +30.4% | 19,500 | -2.5% | 0.83% | -4.1% |
| Q3 2019 | $1,708,000 | -29.5% | 20,000 | -42.9% | 0.86% | +47.1% |
| Q2 2019 | $2,422,000 | +230.9% | 35,000 | +250.0% | 0.59% | +117.0% |
| Q1 2019 | $732,000 | -50.2% | 10,000 | -63.6% | 0.27% | -50.5% |
| Q4 2017 | $1,471,000 | -9.9% | 27,500 | -8.3% | 0.55% | -1.6% |
| Q3 2017 | $1,632,000 | +26.1% | 30,000 | +20.0% | 0.56% | +17.1% |
| Q2 2017 | $1,294,000 | +37.2% | 25,000 | +66.7% | 0.47% | +8.0% |
| Q1 2017 | $943,000 | – | 15,000 | – | 0.44% | – |
| Q4 2016 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |